Quantifying prion disease penetrance using large population control cohorts

Science Translational Medicine
Eric Vallabh MinikelDaniel G MacArthur

Abstract

More than 100,000 genetic variants are reported to cause Mendelian disease in humans, but the penetrance-the probability that a carrier of the purported disease-causing genotype will indeed develop the disease-is generally unknown. We assess the impact of variants in the prion protein gene (PRNP) on the risk of prion disease by analyzing 16,025 prion disease cases, 60,706 population control exomes, and 531,575 individuals genotyped by 23andMe Inc. We show that missense variants in PRNP previously reported to be pathogenic are at least 30 times more common in the population than expected on the basis of genetic prion disease prevalence. Although some of this excess can be attributed to benign variants falsely assigned as pathogenic, other variants have genuine effects on disease susceptibility but confer lifetime risks ranging from <0.1 to ~100%. We also show that truncating variants in PRNP have position-dependent effects, with true loss-of-function alleles found in healthy older individuals, a finding that supports the safety of therapeutic suppression of prion protein expression.

References

Feb 13, 1992·The New England Journal of Medicine·R MedoriP Cortelli
Dec 11, 1991·Proceedings of the National Academy of Sciences of the United States of America·L G GoldfarbD C Gajdusek
Apr 18, 1991·The New England Journal of Medicine·K HsiaoR Gabizon
Apr 1, 1990·Brain Research. Molecular Brain Research·F OwenT J Crow
Nov 1, 1995·Neurology·J A MastrianniJ Y Garbern
Jun 1, 1995·Human Molecular Genetics·J L LaplancheJ M Launay
Dec 1, 1993·Annals of Neurology·M PocchiariY G Xi
Apr 30, 1993·Biochemical and Biophysical Research Communications·T KitamotoJ Tateishi
Jul 2, 1993·Cell·H BüelerC Weissmann
Dec 1, 1995·Brain Research. Molecular Brain Research·S KrasemannW Bodemer
Jun 18, 1998·Annals of Neurology·S ShibuyaT Kitamoto
Oct 24, 1998·Journal of Neuropathology and Experimental Neurology·P PiccardoB Ghetti
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·S B Prusiner
Jan 1, 1999·Lancet·M D'AlessandroM Pocchiari
Jul 2, 1999·Genetics·J F Crow
Oct 20, 1999·Journal of the Neurological Sciences·S Mouillet-RichardJ L Laplanche
Jul 13, 2000·Archives of Neurology·S CollinsC L Masters

❮ Previous
Next ❯

Citations

Jan 23, 2016·Science Translational Medicine·Matthew S LeboRobert C Green
Jun 2, 2016·Proceedings of the National Academy of Sciences of the United States of America·Julian R HomburgerEuan A Ashley
Jun 29, 2016·Acta Neuropathologica·Joel C WattsStanley B Prusiner
Sep 16, 2016·Nature Reviews. Genetics·Orli G Bahcall
Oct 21, 2016·Neuron·Eric Vallabh Minikel, Daniel G MacArthur
Feb 6, 2017·Current Opinion in Genetics & Development·Derick C HoskinsonHeather Mason-Suares
May 19, 2017·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Nicola WhiffinJames S Ware
May 19, 2017·Emerging Infectious Diseases·Patrick UrwinRobert G Will
Dec 13, 2016·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Leonel T TakadaMichael D Geschwind
Jan 18, 2017·Cold Spring Harbor Perspectives in Medicine·Kurt GilesStanley B Prusiner
Feb 27, 2018·Nature Reviews. Genetics·Konrad J Karczewski, Michael P Snyder
Dec 15, 2017·Nature Reviews. Cardiology·James S Ware, Stuart A Cook
Mar 10, 2018·Pathogens·Maria Letizia BarrecaEmiliano Biasini
Jan 9, 2018·Journal of the Endocrine Society·Paul J NeweyRajesh V Thakker
Jan 18, 2018·Journal of Neurochemistry·Michele Christine LandembergerVilma Regina Martins
Aug 6, 2017·Cold Spring Harbor Perspectives in Biology·Mee-Ohk KimMichael D Geschwind
Mar 23, 2018·Human Molecular Genetics·James A DiaoArjun K Manrai
Nov 21, 2017·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Gaël NicolasJoris A Veltman
Oct 25, 2017·European Journal of Epidemiology·M Arfan IkramAlbert Hofman
Nov 3, 2017·Prion·Ricardo Krause Martinez De SouzaRicardo Ramina
Aug 19, 2016·Nature·Monkol LekUNKNOWN Exome Aggregation Consortium
May 12, 2018·Human Mutation·Daniel R EvansKishore Guda
Aug 1, 2018·Molecular Neurobiology·Anna Villar-PiquéFranc Llorens
Sep 6, 2018·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Neus Roca-AyatsAdolfo Díez-Pérez
Sep 12, 2018·Journal of Medical Genetics·Diana E BennRoderick J Clifton-Bligh
Nov 2, 2018·Genes, Chromosomes & Cancer·Mandy L BallingerDavid M Thomas
Nov 20, 2018·Brain Pathology·Daniel PeaseAdriano Aguzzi
Oct 4, 2016·The European Respiratory Journal·Stefan Gräf, Nicholas W Morrell
Oct 19, 2017·Briefings in Bioinformatics·Nicholas P Tatonetti
Jul 7, 2018·Journal of the Endocrine Society·Pavithran ManiamPaul J Newey
May 21, 2019·Journal of Neuropathology and Experimental Neurology·Aušrinė AreškevičiūtėEva Løbner Lund
Oct 14, 2016·Nature·Erika Check Hayden
Aug 2, 2019·Journal of Clinical Microbiology·Allyson ConnorDaniel D Rhoads

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.